EXCEED THE SPACE PROVIDED. In the previous funding period, we used eNOS and iNOS knockout mice to demonstrate that physiologic production of nitric oxide (NO) by endothelial nitric oxide synthase (eNOS) suppresses atherosclerosis, whereas pathologic production of NO by inducible NOS (iNOS) contributes to atherosclerosis. We found that eNOS knockout mice demonstrate an exaggerated response of neointimal proliferation in response to vessel injury. Furthermore, when fed a Western type diet, eNOS/apoE dko mice develop more severe atherosclerosis than do apoE knockout mice, as well as complications of aortic aneurysms, aortic dissection, distal coronary artery disease, myocardial infarction, and ventricular dysfunction. In contrast, iNOS/apoE dko mice develop less atherosclerosis, and show evidence for decreased levels of lipid oxidation. We propose now to extend these results by examining the molecular and cellular mechanisms by which abnormalities in eNOS expression contribute to atherosclerosis. Specifically, we hypothesize that abnormalities in eNOS phosphorylation at serine 1179 and threonine 497 underlie the molecular mechanisms of endothelial dysfunction, and that statins and estrogens exert their beneficial effects by correcting these abnormalities. We are generating transgenic and knockin mice that carry mutations at these phosphorylation sites, to mimic both the phosphorylated form (aspartate substitution) and an unphosphorylatable form (alanine substitution). These mice will be useful tools to determine the extent to which abnormalities in phosphorylation lead to increased vessel injury response, and propensity to diet induced atherosclerosis in the apoE knockout mouse model. A second hypothesis is that expression of NOS isoforms by circulating cells, in addition to vascular endothelium and smooth muscle, affects atherosclerosis. We propose to use bone marrow transplantation studies to assess the importance of NOS isoform expression by bone marrow-derived cells to vessel injury and atherosclerosis in vivo. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057818-08
Application #
6834569
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Srinivas, Pothur R
Project Start
1998-01-01
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
8
Fiscal Year
2005
Total Cost
$266,250
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Turcot, Valérie (see original citation for additional authors) (2018) Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet 50:26-41
Pong, Terrence; Scherrer-Crosbie, Marielle; Atochin, Dmitriy N et al. (2014) Phosphomimetic modulation of eNOS improves myocardial reperfusion and mimics cardiac postconditioning in mice. PLoS One 9:e85946
Kashiwagi, Satoshi; Atochin, Dmitriy N; Li, Qian et al. (2013) eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity. Biochem Biophys Res Commun 431:284-90
Li, Qian; Atochin, Dmitriy; Kashiwagi, Satoshi et al. (2013) Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke 44:3183-8
Zhang, Xiuqin; Zhang, Rongli; Raab, Susanne et al. (2011) Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone. Circulation 124:77-86
Daumerie, Geraldine; Bridges, Lakeesha; Yancey, Sadiqa et al. (2010) The effect of salt on renal damage in eNOS-deficient mice. Hypertens Res 33:170-6
Kuhlencordt, Peter J; Padmapriya, P; Rützel, S et al. (2009) Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. Atherosclerosis 202:48-57
Schödel, Johannes; Padmapriya, P; Marx, Alexander et al. (2009) Expression of neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout mice. Atherosclerosis 206:383-9
Liu, Victor W T; Huang, Paul L (2008) Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 77:19-29
Yamova, Liubov; Atochin, Dmitriy; Glazova, Margarita et al. (2007) Role of neuronal nitric oxide in the regulation of vasopressin expression and release in response to inhibition of catecholamine synthesis and dehydration. Neurosci Lett 426:160-5

Showing the most recent 10 out of 28 publications